Genetic diagnosis by comparative genomic hybridization in adult de novo acute myelocytic leukemia

Cancer Genetics and Cytogenetics

Volumn 153, Issue 1, 2004, Pages 16-25

  Casas, Sílvia ^a   Aventín, Anna ^a   Fuentes, Francisca ^a   Vallespí, Teresa ^b   Granada, Isabel ^c   Carrió, Anna ^d   Angel Martínez Climent, José ^e   Solé, Francesc ^f   Teixidó, Montserrat ^g   Bernués, Marta ^h   Duarte, José ⁱ   Maria Hernández, Jesús ^j   Brunet, Salut ^a   Dolors Coll, Maria ^k   Sierra, Jorge ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e Hospital Clinic   (Spain)

^f HOSPITAL DEL MAR   (Spain)

^g HOSPITAL ARNAU DE VILANOVA   (Spain)

^h HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

ⁱ Genetics Laboratory   (Spain)

^j HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^k UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHROMOSOME 16Q; CHROMOSOME 17P; CHROMOSOME 5Q; CHROMOSOME 7; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME DISORDER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENE NUMBER; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; METAPHASE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; ACUTE DISEASE; COMPARATIVE STUDY; EVALUATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENETICS; HUMAN CHROMOSOME; KARYOTYPING; MIDDLE AGED; MYELOID LEUKEMIA; NUCLEIC ACID HYBRIDIZATION; REFRACTORY ANEMIA WITH EXCESS BLASTS; TRISOMY; ULTRASTRUCTURE;

ACUTE DISEASE; ADOLESCENT; ADULT; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; SEQUENCE DELETION; TRISOMY;

EID: 4644224836     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2003.12.011     Document Type: Article

References (42)

1. Grimwade D., Walker H., Oliver F., Wheatley K., Harrison C., Harrison G., Rees J., Hann I., Stevens R., Burnett A., Goldstone A. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood. 92:1998;2322-2333
2. Bloomfield C.D., Lawrence D., Byrd J.C., Carroll A., Pettenati M.J., Tantravahi R., Patil S.R., Davey F.R., Berg D.T., Schiffer C.A., Arthur D.C., Mayer R.J. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res. 58:1998;4173-4179
3. Mrozek K., Bloomfield C.D. Chromosome aberrations in de novo acute myeloid leukemia in adults: clinical implications. Rev Clin Exp Hematol. 5:1998;44-67
4. Kearney L. Molecular cytogenetics. Best Pract Res Clin Haematol. 14:2001;645-668
5. Kallioniemi A., Kallioniemi O.P., Sudar D., Rutovitz D., Gray J.W., Waldman F., Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 258:1992;818-821
6. Forozan F., Karhu R., Kononen J., Kallioniemi A., Kallioniemi O.P. Genome screening by comparative genomic hybridization. Trends Genet. 13:1997;405-409
7. Struski S., Doco-Fenzy M., Cornillet-Lefebvre P. Compilation of published comparative genomic hybridization studies. Cancer Genet Cytogenet. 135:2002;63-90
8. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 103:1985;620-625
9. World Health Organization. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. 1st edition:2001;IARC Press, Lyon
10. Mitelman F, editor. An international system for human cytogenetic nomenclature. Mitelman F. 2nd edition:1995;S. Karger, Basel
11. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215
12. El-Rifai W., Elonen E., Larramendy M., Ruutu T., Knuutila S. Chromosomal breakpoints and changes in DNA copy number in refractory acute myeloid leukemia. Leukemia. 11:1997;958-963
13. Castuma M.V., Rao P.H., Acevedo S.H., Larripa I.B. Comparative genomic hybridization study of de novo myeloid neoplasia. Acta Haematol. 104:2000;25-30
14. Lindvall C., Nordenskjold M., Porwit A., Bjorkholm M., Blennow E. Molecular cytogenetic characterization of acute myeloid leukemia and myelodysplastic syndromes with multiple chromosome rearrangements. Haematologica. 86:2001;1158-1164
15. Verdorfer I., Brecevic L., Saul W., Schenker B., Kirsch M., Trautmann U., Helm G., Gramatzki M., Gebhart E. Comparative genomic hybridization-aided unraveling of complex karyotypes in human hematopoietic neoplasias. Cancer Genet Cytogenet. 124:2001;1-6
16. Wang P., Spielberger R.T., Thangavelu M., Zhao N., Davis E.M., Iannantuoni K., Larson R.A., Le Beau M.M. dic(5;17): a recurring abnormality in malignant myeloid disorders associated with mutations of TP53. Genes Chromosomes Cancer. 20:1997;282-291
17. Betts D.R., Rohatiner A.Z., Evans M.L., Rassam S.M., Lister T.A., Gibbons B. Abnormalities of chromosome 16q in myeloid malignancy: 14 new cases and a review of the literature. Leukemia. 6:1992;1250-1256
18. Marlton P., Keating M., Kantarjian H., Pierce S., O'Brien S., Freireich E.J., Estey E. Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16. Leukemia. 9:1995;965-971
19. Yamamoto K., Nagata K., Kida A., Hamaguchi H. Deletion of 16q11 is a recurrent cytogenetic aberration in acute myeloblastic leukemia during disease progression. Cancer Genet Cytogenet. 131:2001;65-68
20. Langabeer S.E., Grimwade D., Walker H., Rogers J.R., Burnett A.K., Goldstone A.H., Linch D.C. A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia. MRC Adult Leukaemia Working Party. Medical Research Council. Br J Haematol. 101:1998;338-340
21. Mitelman Database of Chromosome Aberrations in Cancer. Mitelman F, Johansson, B, Mertens, F, editors. Available at: http://www.cgap. nci.nih.gov/Chromosomes/Mitelman. Accessed September 11, 2003.
22. Bentz M., Dohner H., Huck K., Schutz B., Ganser A., Joos S., du Manoir S., Lichter P. Comparative genomic hybridization in the investigation of myeloid leukemias. Genes Chromosomes Cancer. 12:1995;193-200
23. Huhta T., Vettenranta K., Heinonen K., Kanerva J., Larramendy M.L., Mahlamaki E., Saarinen-Pihkala U.M., Knuutila S. Comparative genomic hybridization and conventional cytogenetic analyses in childhood acute myeloid leukemia. Leuk Lymphoma. 35:1999;311-315
24. Mohamed A.N., Macoska J.A., Kallioniemi A., Kallioniemi O.P., Waldman F., Ratanatharathorn V., Wolman S.R. Extrachromosomal gene amplification in acute myeloid leukemia; characterization by metaphase analysis, comparative genomic hybridization, and semi-quantitative PCR. Genes Chromosomes Cancer. 8:1993;185-189
25. Crossen P.E., Morrison M.J., Rodley P., Cochrane J., Morris C.M. Identification of amplified genes in a patient with acute myeloid leukemia and double minute chromosomes. Cancer Genet Cytogenet. 113:1999;126-133
26. Cooperman B.S., Klinger H.P. Double minute chromosomes in a case of acute myelogenous leukemia resistant to chemotherapy. Cytogenet Cell Genet. 30:1981;25-30
27. Rechavi G., Berkowicz M., Rosner E., Neuman Y., Ben-Bassat I., Ramot B. Chromosomal aberrations suggestive of mutagen-related leukemia after 21 years of "therapeutic" radon exposure. Cancer Genet Cytogenet. 48:1990;125-130
28. Barlund M., Tirkkonen M., Forozan F., Tanner M.M., Kallioniemi O., Kallioniemi A. Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions. Genes Chromosomes Cancer. 20:1997;372-376
29. Kallioniemi A., Kallioniemi O.P., Piper J., Tanner M., Stokke T., Chen L., Smith H.S., Pinkel D., Gray J.W., Waldman F.M. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA. 91:1994;2156-2160
30. Tanner M.M., Tirkkonen M., Kallioniemi A., Isola J., Kuukasjarvi T., Collins C., Kowbel D., Guan X.Y., Trent J., Gray J.W., Meltzer P., Kallioniemi O.P. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res. 56:1996;3441-3445
31. Kiyoi H., Towatari M., Yokota S., Hamaguchi M., Ohno R., Saito H., Naoe T. Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product. Leukemia. 12:1998;1333-1337
32. Roumier C., Fenaux P., Lafage M., Imbert M., Eclache V., Preudhomme C. New mechanisms of AML1 gene alteration in hematological malignancies. Leukemia. 17:2003;9-16
33. Riboni R., Casati A., Nardo T., Zaccaro E., Ferretti L., Nuzzo F., Mondello C. Telomeric fusions in cultured human fibroblasts as a source of genomic instability. Cancer Genet Cytogenet. 95:1997;130-136
34. Kallioniemi O.P., Kallioniemi A., Piper J., Isola J., Waldman F.M., Gray J.W., Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer. 10:1994;231-243
35. Cuneo A., Bigoni R., Cavazzini F., Bardi A., Roberti M.G., Agostini P., Tammiso E., Ciccone N., Mancini M., Nanni M., De Cuia R., Divona M., La Starza R., Crescenzi B., Testoni N., Rege Cambrin G., Mecucci C., Lo Coco F., Saglio G., Castoldi G. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype. Leukemia. 16:2002;1745-1751
36. Casas S., Aventin A., Nomdedeu J., Sierra J. Cryptic t(5;11)(q35;p15.5) in adult de novo acute myelocytic leukemia with normal karyotype. Cancer Genet Cytogenet. 145:2003;183
37. Wilkens L., Tchinda J., Burkhardt D., Nolte M., Werner M., Georgii A. Analysis of hematologic diseases using conventional karyotyping, fluorescence in situ hybridization (FISH), and comparative genomic hybridization (CGH). Hum Pathol. 29:1998;833-839
38. Dalley C.D., Neat M.J., Foot N.J., Burridge M., Byrne L., Amess J.A., Rohatiner A.Z., Lister A., Young B.D., Lillington D.M. Comparative genomic hybridization and multiplex-fluorescence in situ hybridization: an appraisal in elderly patients with acute myelogenous leukemia. Hematol J. 3:2002;290-298
39. Solinas-Toldo S., Lampel S., Stilgenbauer S., Nickolenko J., Benner A., Dohner H., Cremer T., Lichter P. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer. 20:1997;399-407
40. Lichter P., Joos S., Bentz M., Lampel S. Comparative genomic hybridization: uses and limitations. Semin Hematol. 37:2000;348-357
41. Aventin A., La Starza R., Nomdedeu J., Brunet S., Sierra J., Mecucci C. Typical CBFbeta/MYH11 fusion due to insertion of the 3′-MYH11 gene into 16q22 in acute monocytic leukemia with normal chromosomes 16 and trisomies 8 and 22. Cancer Genet Cytogenet. 123:2000;137-139
42. Aventin A., La Starza R., Casas S., Nomdedeu J., Queipo de Llano M.P., Cimino G., Lo Coco F., Sierra J., Mecucci C. MLL tandem duplication in two cases of acute myelocytic leukemia with unbalanced translocations: der(16)t(11;16)(q23;p13) and der(18)t(11;18)(q22; p11.2). Cancer Genet Cytogenet. 142:2003;8-12